Magnesium Chloride injection recalled due to lack of sterility assurance
Olympia Compounding Pharmacy is recalling 1,597 vials of Magnesium Chloride injection due to lack of sterility assurance. The product was distributed nationwide in the USA, Puerto Rico, and the US Virgin Islands.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable pharmaceutical product due to lack of sterility assurance. No reported illnesses or injuries. The lack of reported harm and theoretical nature of the hazard limits the score to 3 per the rubric.
Plain-English summary
Olympia Compounding Pharmacy is recalling 1,597 vials of Magnesium Chloride injection (200 mg/mL, NDC 73198-0072-30, Lot A24012-22). The product was distributed nationwide in the United States, Puerto Rico, and the US Virgin Islands.
The recall was initiated because the manufacturer cannot provide assurance that the product meets sterility standards required for injectable use. Magnesium Chloride injection is administered intravenously and requires confirmed sterility to ensure patient safety.
Healthcare providers and facilities with this product in inventory should cease use of the affected lot immediately. Any individuals who may have received this product should consult their healthcare provider regarding potential health effects from exposure to a non-sterile injectable product.
The recalled product
- Product
- Magnesium Chloride, 200 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0072-30.
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Category
- Drug — Injectable / Parenteral
- Hazard
- lack-of-sterility
- bacterial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: A24012-22 BUD: 7/12/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27